Terumo Corp  

(Public, TYO:4543)   Watch this stock  
Find more results for 4543
2,301.00
-12.00 (-0.52%)
Delayed:   1:59PM GMT+9
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 2,293.00 - 2,322.00
52 week 1,954.00 - 2,730.00
Open 2,316.00
Vol / Avg. 773,100.00/1.38M
Mkt cap 873.81B
P/E 25.63
Div/yield 14.50/1.26
EPS 89.78
Shares 379.75M
Beta     -
Inst. own     -
Aug 6, 2014
Q1 2015 TERUMO CORP Earnings Conference Call (Japanese) - 4:30PM GMT+9 - Add to calendar
Aug 6, 2014
Q1 2015 TERUMO CORP Earnings Release - 3:00PM GMT+9 - Add to calendar
Jun 24, 2014
TERUMO CORP Annual Shareholder Meeting (Japanese)
May 8, 2014
Full Year 2014 TERUMO CORP Earnings Presentation and Webcast (Japanese) - Webcast
May 8, 2014
Full Year 2014 TERUMO CORP Earnings Release
May 8, 2014
Full Year 2014 TERUMO CORP Earnings Presentation Webcast
  

Key stats and ratios

Q1 (Mar '14) 2014
Net profit margin -2.29% 7.30%
Operating margin 0.99% 11.55%
EBITD margin - 22.50%
Return on average assets -1.32% 4.26%
Return on average equity -2.23% 7.30%
Employees 19,263 -
CDP Score - -

Address

2-44-1, Hatagaya
SHIBUYA-KU, TKY 151-0072
Japan
+81-3-33748111 (Phone)
+81-3-33748399 (Fax)

Website links

Description

TERUMO CORPORATION is manufacturer of medical supplies. The Hospital Products segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The Cardiac and Vascular Area segment is involved in the manufacture, purchase and sale of catheter systems, artificial heart and lungs, as well as artificial blood vessels, the manufacture and sale of therapeutic coils for cerebral aneurysm, sampling equipment and kits for platelet-rich plasma and concentrated bone-marrow cell, and large-bore sheaths. The Blood System segment is engaged in the manufacture, purchase and sale of blood transfusion-related products. It also manufactures and sells healthcare related products. As of March 31, 2013, the Company had 79 subsidiaries and 2 associated companies.

Officers and directors

Koji Nakao Chairman of the Board, Representative Director
Age: 66
Yutaro Shintaku President, Representative Director
Age: 57
Hiroshi Matsumura Executive Vice President, Director
Age: 59
Takayoshi Mimura Senior Managing Executive Officer, Chairman and General Manager of Subsidiary, Director
Age: 60
Akira Oguma Senior Managing Executive Officer, Director
Age: 61
Narushige Toda Senior Executive Officer, Director of Domestic Sales in Hospital Company
Hideo Arase Senior Executive Officer, President & CEO of Subsidiary, Director
Age: 58
David Perez Senior Executive Officer, President & Chief Executive Officer of Subsidiary, Director
Shinjiro Sato Senior Executive Officer, Director
Kuniko Shoji Senior Executive Officer, Director of Medicine Business, Director of Clinical Development, Director
Age: 59